Allogeneic bone marrow transplantation is an effective treatment of leukemia. Intensive
chemo‐and radiotherapy used for conditioning and T‐cells of the graft contribute to the …

The immune reactivity of allogeneic lymphocytes plays a major role in the control of
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …

Four patients with acute myeloid leukaemia relapsed within 6 months of allogeneic BMT.
Three patients were treated with cytosine arabinoside and amsacrine while the fourth …

Treatment of recurrent leukemia after bone marrow transplantation with the transfusion of
lymphocytes from the marrow donor has been successful in a majority of patients with …

Relapse remains a significant problem after allogeneic bone marrow transplantation (BMT).
For patients with relapsed chronic myelogenous leukemia (CML), infusions of donor …

Fourteen patients with chronic myeloid leukemia (CML) relapsing after allogeneic bone
marrow transplant (BMT) were treated with leukocyte transfusions from the original marrow …

Donor leukocyte infusions were administered to a patient who had relapsed with chronic
myelogenous leukemia after having failed two successive HLA-matched allogeneic bone …

Allogeneic bone marrow transplantation (BMT) is the treatment of choice for hematologic
malignancies resistant to conventional chemotherapy and for patients who are at high risk …

To clarify the role of donor leukocyte infusion (DLI) in the treatment of leukemia relapsing
after allo-BMT, data from 100 patients were collected from 46 facilities in Japan and …

We assessed the chimerism of CD34+ bone marrow cells before donor leukocyte infusion
(DLI) on nine occasions in seven patients with leukemic relapse after allogeneic marrow …